Patrik Nasr
Linkoeping, E, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Fibroblast activation protein and down-stream effects on its substrates in metabolic dysfunction-associated steatotic liver disease.
Journal: Scandinavian journal of gastroenterology
Published: June 03, 2026
Observations of blue-stripe artefacts in 2D SWE not reported in guidelines and their influence on diagnostic accuracy-A technical note.
Journal: Radiology case reports
Published: March 13, 2026
Metabolic biomarkers add little to diagnostic performance of FIB-4 in MASLD.
Journal: Scandinavian journal of gastroenterology
Published: February 06, 2026
Assessing alcohol consumption in an era of direct alcohol markers.
Journal: JHEP reports : innovation in hepatology
Published: February 04, 2026
Chronic Liver Disease: Assessing Inflammation and Fibrosis Using Three-Dimensional MR Elastography With Same-Day Biopsy in a Prospective Cohort.
Journal: Journal of magnetic resonance imaging : JMRI
Published: December 22, 2025
Clinical relevance and reproducibility of morphological MRI findings in liver cirrhosis: Results from ACCESS-ESLD.
Journal: European journal of radiology
Published: December 19, 2025
A comparative study between ultrasound-guided-attenuation-parameter (UGAP), controlled attenuation parameter (CAP), and proton density fat fraction (PDFF) for assessment of hepatic steatosis.
Journal: Scandinavian journal of gastroenterology
Published: November 30, 2025
Associations between fat distribution and obstructive sleep apnea severity among individuals with type 2 diabetes: an MRI-based study.
Journal: Scientific reports
Published: August 20, 2025
Detection of hepatic steatosis with ultrasound-guided attenuation parameter (UGAP) in metabolic dysfunction-associated steatotic liver disease (MASLD) compared with proton density fat fraction (PDFF): Impact of measurement number and region of interest (ROI) location.
Journal: Ultrasound (Leeds, England)
Published: August 11, 2025
Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care.
Journal: Journal of internal medicine
Published: June 16, 2025
Last Updated: 09/26/2026